Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Immunome (IMNM) Return on Assets: 2023-2025

Historic Return on Assets for Immunome (IMNM) over the last 2 years, with Sep 2025 value amounting to -0.79%.

  • Immunome's Return on Assets rose 36.00% to -0.79% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.79%, marking a year-over-year increase of 36.00%. This contributed to the annual value of -1.57% for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Immunome's Return on Assets is -0.79%, which was down 11.86% from -0.70% recorded in Q2 2025.
  • Immunome's 5-year Return on Assets high stood at -0.70% for Q2 2025, and its period low was -1.23% during Q4 2024.
  • Its 3-year average for Return on Assets is -0.93%, with a median of -0.89% in 2023.
  • In the last 5 years, Immunome's Return on Assets crashed by 32bps in 2024 and then surged by 36bps in 2025.
  • Over the past 3 years, Immunome's Return on Assets (Quarterly) stood at -0.91% in 2023, then slumped by 32bps to -1.23% in 2024, then spiked by 36bps to -0.79% in 2025.
  • Its Return on Assets was -0.79% in Q3 2025, compared to -0.70% in Q2 2025 and -0.75% in Q1 2025.